Immunological assessment of plant-derived avian flu H5/HA1 variants

Vaccine

Volumn 27, Issue 9, 2009, Pages 1289-1292

  Spitsin, S ^a   Andrianov, V ^a   Pogrebnyak, N ^a   Smirnov, Y ^a   Borisjuk, N ^a   Portocarrero, C ^a   Veguilla, V ^b   Koprowski, H ^a   Golovkin, M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Avian flu H5N1; Plant biotechnology; Recombinant subunit vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AVIAN INFLUENZA VACCINE; CPG OLIGODEOXYNUCLEOTIDE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INFLUENZA VIRUS A H5N1 HEMAGGLUTININ 1 PROTEIN; MYC PROTEIN; NEUTRALIZING ANTIBODY; POLYHISTIDINE TAG; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PLANT GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN VARIANT; STABLE EXPRESSION; TOBACCO; TRANSGENIC PLANT; TRANSIENT EXPRESSION; VACCINE PRODUCTION;

ANIMALS; ANTIBODY FORMATION; BIRDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; PLANT PROTEINS;

EID: 59649121116     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.050     Document Type: Article

References (19)

1. Webster R.G., and Govorkova E.A. H5N1 influenza - continuing evolution and spread. N Engl J Med 355 21 (2006) 2174-2177
2. Bardiya N., and Bae J.H. Influenza vaccines: recent advances in production technologies. Appl Microbiol Biotechnol 67 (2005) 299-305
3. Caton A.J., Brownlee G.G., Yewdell J.W., and Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31 (1982) 417-427
4. Tonegawa K., Nobusawa E., Nakajima K., Kato T., Kutsuna T., Kuroda K., et al. Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus. Vaccine 21 (2003) 3118-3125
5. Rybicki E.P. Plant-produced vaccines: promise and reality. Drug Discov Today 14 (2009) 16-24
6. Golovkin M., Spitsin S., Andrianov V., Smirnov Y., Xiao Y., Pogrebnyak N., et al. Smallpox subunit vaccine produced in planta confers protection in mice. Proc Natl Acad Sci USA 104 (2007) 6864-6869
7. Ko K., Tekoah Y., Rudd P.M., Harvey D.J., Dwek R.A., Spitsin S., et al. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci USA 100 13 (2003) 8013-8018
8. Ko K., Steplewski Z., Glogowska M., and Koprowski H. Inhibition of tumor growth by plant-derived mAb. Proc Natl Acad Sci USA 102 19 (2005) 7026-7030
9. Pogrebnyak N., Golovkin M., Andrianov V., Spitsin S., Smirnov Y., Egolf R., et al. Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. Proc Natl Acad Sci USA 102 25 (2005) 9062-9067
10. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37 (1999) 937-943
11. Shoji Y., Chichester J.A., Bi H., Musiychuk K., de la Rosa P., Goldschmidt L., et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 26 (2008) 2930-2934
12. Wei C.J., Xu L., Kong W.P., Shi W., Canis K., Stevens J., et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 82 13 (2008) 6200-6208
13. Okamoto S., Yoshii H., Akagi T., Akashi M., Ishikawa T., Okuno Y., et al. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Vaccine 25 49 (2007) 8270-8278
14. Garg S., Hoelscher M., Belser J.A., Wang C., Jayashankar L., Guo Z., et al. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol 14 7 (2007) 926-928
15. Kreijtz J.H., Suezer Y., van Amerongen G., de Mutsert G., Schnierle B.S., Wood J.M., et al. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J Infect Dis 195 11 (2007) 1598-1606
16. Obregon P., Chargelegue D., Drake P.M., Prada A., Nuttall J., Frigerio L., et al. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J 4 (2006) 195-207
17. Treanor J.J., Campbell J.D., Zangwill K.M., Rowe T., and Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354 13 (2006) 1343-1351
18. Portocarrero C., Markley K., Koprowski H., Spitsin S., and Golovkin M. Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5. Vaccine 26 43 (2008) 5535-5540
19. Stephenson I., Bugarini R., Nicholson K.G., Podda A., Wood J.M., Zambon M.C., et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 191 8 (2005) 1210-1215